Td Asset Management Inc Replimune Group, Inc. Transaction History

Td Asset Management Inc

$108 Billion
Q2 2025

A detailed history of Td Asset Management Inc transactions in Replimune Group, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 327,452 shares of REPL stock, worth $2.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

327,452

Previous 275,852 18.71%

Holding current value

$2.47 Million

Previous $2.69 Million 13.13%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	BUY	$6.92 - $10.38 $357,072 - $535,608	51,600 Added 18.71%	327,452 $3.04 Million
Q1 2025 May 07, 2025	SELL	$9.75 - $14.31 $179,848 - $263,962	-18,446 Reduced 6.27%	275,852 $2.69 Million
Q4 2024 Feb 11, 2025	BUY	$10.54 - $14.93 $386,565 - $547,572	36,676 Added 14.24%	294,298 $3.56 Million
Q3 2024 Nov 01, 2024	BUY	$8.09 - $11.23 $62,147 - $86,268	7,682 Added 3.07%	257,622 $2.82 Million
Q2 2024 Aug 02, 2024	BUY	$5.01 - $9.46 $55,580 - $104,949	11,094 Added 4.64%	249,940 $2.25 Million
Q1 2024 May 08, 2024	SELL	$6.87 - $9.31 $197,856 - $268,128	-28,800 Reduced 10.76%	238,846 $1.95 Million
Q3 2023 Oct 27, 2023	BUY	$15.96 - $22.18 $2.14 Million - $2.97 Million	133,823 Added 100.0%	267,646 $4.58 Million
Q2 2023 Aug 09, 2023	SELL	$15.65 - $24.1 $168,081 - $258,834	-10,740 Reduced 7.43%	133,823 $3.11 Million
Q1 2023 May 10, 2023	BUY	$17.48 - $29.09 $202,768 - $337,444	11,600 Added 8.72%	144,563 $2.55 Million
Q4 2022 Feb 06, 2023	BUY	$17.09 - $27.91 $477,870 - $780,419	27,962 Added 26.63%	132,963 $3.62 Million
Q2 2022 Aug 04, 2022	SELL	$13.32 - $19.98 $166,793 - $250,189	-12,522 Reduced 10.65%	105,001 $1.84 Million
Q1 2022 May 10, 2022	SELL	$15.24 - $29.75 $165,171 - $322,430	-10,838 Reduced 8.44%	117,523 $2 Million
Q4 2021 Feb 10, 2022	BUY	$25.43 - $34.25 $294,631 - $396,820	11,586 Added 9.92%	128,361 $3.48 Million
Q3 2021 Nov 09, 2021	BUY	$28.98 - $39.54 $362,250 - $494,250	12,500 Added 11.99%	116,775 $3.46 Million
Q2 2021 Aug 11, 2021	BUY	$28.5 - $39.37 $878,883 - $1.21 Million	30,838 Added 41.99%	104,275 $3.41 Million
Q1 2021 May 14, 2021	BUY	$30.22 - $45.57 $230,759 - $347,972	7,636 Added 11.6%	73,437 $2.24 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $1.06 Million - $2.37 Million	45,101 Added 217.88%	65,801 $2.51 Million
Q2 2020 Aug 13, 2020	BUY	$9.76 - $25.95 $202,032 - $537,165	20,700 New	20,700 $514,000

Others Institutions Holding REPL

# of Institutions

168

Shares Held

78.5M

Call Options Held

69.4K

Put Options Held

216K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $372M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Replimune Group, Inc. Transaction History